Table 3.
Frequency and Weighted Percentages, and Adjusted Correlates, of Concomitant Vaccination Among Male Adolescents (N=34,370)
| Tetanus, diphtheria, and acellular pertussis (Tdap) booster |
Meningococcal conjugate and unknown type meningococcal vaccine (MenACWY) |
Human papillomavirus (HPV) vaccinea |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Characteristic | n/N | % | O R |
95% CI |
n/N | % | OR | 95% CI | n/N | % | O R |
95% CI |
| Overall | 14,428/ 30,912 |
48.3 | 14,612/ 28,629 |
52.5 | 757/ 3,328 |
25.0 | ||||||
| Survey year | ||||||||||||
| 2008 | 809/ 2,332 |
35.1 | (ref) | 809/ 2,548 |
31.4 | (ref) | --b | 36.5 | (ref) | |||
| 2009 | 1,685/ 4,643 |
39.2 | 1.20 | (0.98–1.46) | 1,684/ 4,555 |
39.6 | 1.44 | (1.18–1.76)** | --b | 29.5 | 0.71 | (0.07–6.77) |
| 2010 | 2,651/ 6,202 |
45.8 | 1.65 | (1.37–1.99)** | 2,667/ 5,686 |
50.3 | 2.36 | (1.96–2.84)** | 55/ 176 |
35.0 | 0.98 | (0.17–5.81) |
| 2011 | 4,622/ 9,283 |
51.6 | 2.13 | (1.78–2.56)** | 4,689/ 8,363 |
56.8 | 3.15 | (2.64–3.77)** | 226/ 1,055 |
22.8 | 0.41 | (0.08–2.18) |
| 2012 | 4,661/ 8,452 |
56.1 | 2.62 | (2.16–3.16)** | 4,763/ 7,477 |
65.2 | 4.58 | (3.78–5.55)** | 465/ 2,063 |
25.1 | 0.56 | (0.11–2.94) |
|
Adolescent characteristic |
||||||||||||
| Age at interview (continuous) |
0.74 | (0.72–0.77)** | 0.65 | (0.62–0.67)** | 0.71 | (0.62–0.81)** | ||||||
| Race/ethnicity | ||||||||||||
| Non- Hispanic white |
9,493/ 21,207 |
45.5 | (ref) | 9,612/ 19,172 |
50.4 | (ref) | 390/ 1,815 |
24.9 | (ref) | |||
| Non- Hispanic black |
1,597/ 3,031 |
54.1 | 1.35 | (1.16–1.57)** | 1,607/ 3,071 |
56.3 | 1.31 | (1.13–1.53)** | 97/ 462 |
24.8 | 0.76 | (0.46–1.26) |
| Hispanic | 2,128/ 4,150 |
52.4 | 1.16 | (1.00–1.34)* | 2,166/ 3,991 |
54.9 | 1.02 | (0.87–1.19) | 188/ 719 |
26.6 | 0.72 | (0.40–1.30) |
| Other | 1,210/ 2,524 |
47.8 | 0.97 | (0.82–1.15) | 1,227/ 2,395 |
50.6 | 0.83 | (0.69–1.00) | 82/ 332 |
19.8 | 0.73 | (0.42–1.30) |
| Private health insurance |
||||||||||||
| No | 4,799/ 9,678 |
51.6 | (ref) | 4,878/ 8,985 |
55.7 | (ref) | 391/ 1,429 |
28.5 | (ref) | |||
| Yes | 9,557/ 21,071 |
46.0 | 0.97 | (0.86–1.08) | 9,659/ 19,484 |
49.8 | 0.99 | (0.88–1.12) | 362/ 1,878 |
20.8 | 0.83 | (0.54–1.29) |
| Preventive check-up in last year |
||||||||||||
| No | 1,674/ 3,400 |
52.3 | (ref) | 1,686/ 2,698 |
64.2 | (ref) | 69/ 163 |
36.6 | (ref) | |||
| Yes | 12,754/ 27,512 |
47.7 | 0.87 | (0.76–1.01) | 12,926/ 26,931 |
50.8 | 0.59 | (0.50–0.70)** | 688/ 3,165 |
24.3 | 0.67 | (0.33–1.37) |
|
Household characteristic |
||||||||||||
| Mother's age | ||||||||||||
| ≤ 34 years | 1,306/ 2,341 |
57.2 | (ref) | 1,315/ 2,130 |
63.2 | (ref) | 119/ 338 |
38.2 | (ref) | |||
| 35–44 years | 6,380/ 12,956 |
49.8 | 0.92 | (0.77–1.10) | 6,453/ 11,790 |
54.3 | 0.88 | (0.73–1.08) | 351/ 1,402 |
24.7 | 1.15 | (0.66–2.01) |
| ≥ 45 years | 6,742/ 15,615 |
44.8 | 0.92 | (0.76–1.10) | 6,844/ 14,709 |
47.8 | 0.85 | (0.40–1.04) | 287/ 1,588 |
20.7 | 1.34 | (0.73–2.46) |
| Mother's education level |
||||||||||||
| High school or less |
4,267/ 8,662 |
50.0 | (ref) | 4,335/ 8,053 |
54.5 | (ref) | 314/ 1,148 |
28.6 | (ref) | |||
| At least some college |
10,161/ 22,250 |
47.1 | 0.92 | (0.82–1.02) | 10,277/ 20,576 |
50.7 | 0.89 | (0.80–1.00) | 443/ 2,180 |
21.7 | 0.79 | (0.53–1.18) |
| Annual income | ||||||||||||
| Below poverty level |
2,255/ 4,281 |
52.9 | (ref) | 2,298/ 4,098 |
56.8 | (ref) | 229/ 778 |
31.3 | (ref) | |||
| Above poverty level |
11,670/ 25,453 |
47.2 | 0.95 | (0.81–1.11) | 11,802/ 23,410 |
51.2 | 1.00 | (0.85–1.18) | 507/ 2,433 |
22.1 | 0.67 | (0.71–1.08) |
| Unknown | 503/ 1,178 |
45.4 | 0.97 | (0.75–1.24) | 512/ 1,121 |
49.0 | 1.01 | (0.77–1.32) | 21/ 117 |
14.1 | 0.59 | (0.23–1.51) |
| Urbanicity | ||||||||||||
| Non- metropolitan |
2,370/ 5,703 |
44.9 | (ref) | 2,417/ 4,552 |
55.7 | (ref) | 179/ 489 |
37.8 | (ref) | |||
| Metropolitan | 10,209/ 21,933 |
47.2 | 1.16 | (1.05–1.30)* |
10,308/ 21,136 |
49.5 | 0.85 | (0.75–0.96)* |
388/ 2,107 |
20.1 | 0.49 | (0.33–0.73)** |
| Census region | ||||||||||||
| South | 5,368/ 10,446 |
50.4 | (ref) | 5,422/ 10,095 |
54.8 | (ref) | 596/ 1,202 |
28.1 | (ref) | |||
| Midwest | 3,300/ 6,852 |
49.0 | 1.11 | (0.99–1.23) | 3,331/ 5,142 |
54.6 | 1.13 | (1.01–1.27)* | 158/ 594 |
28.5 | 1.15 | (0.74–1.80) |
| Northeast | 2,668/ 6,644 |
41.4 | 0.78 | (0.70–0.87)** | 2,700/ 6,620 |
41.4 | 0.68 | (0.61–0.77)** | 91/ 803 |
13.3 | 0.43 | (0.25–0.76)* |
| West | 3,092/ 6,970 |
49.9 | 1.10 | (0.96–1.26) | 3,159/ 5,772 |
55.6 | 1.24 | (1.0–-1.44)* | 212/ 729 |
25.7 | 0.86 | (0.54–1.38) |
| Number of children in household |
||||||||||||
| 1 | 4,833/ 11,302 |
44.6 | (ref) | 4,902/ 10,528 |
48.3 | (ref) | 241/ 1,137 |
25.7 | (ref) | |||
| 2 or more | 9,595/ 19,610 |
49.8 | 1.07 | (0.97–1.17) | 9,710/ 18,101 |
53.8 | 1.01 | (0.91–1.11) | 516/ 2,191 |
24.8 | 0.84 | (0.58–1.23) |
Notes: Results for each vaccine come from a single multivariable model, reflecting adjusted ORs. Frequencies are unweighted, and percentages (and ORs) are weighted. Overall n (34,370) represents male adolescents who received at least one vaccine under study, and column ns represent male adolescents who received the respective vaccine. In keeping with NIS-Teen norms, we include an “Unknown” group for Annual income but not for other variables.
Boldface indicates statistical significance (*p<0.05; **p<0.01).
a
HPV vaccine initiation (receipt of first dose) only.
b
Frequency suppressed due to small cell size (<10 observations).